Bromhexine, for post exposure COVID-19 prophylaxis: A Randomized, Double-Blind, Placebo Control Trial

Abstract excerpt

<h4>Purpose: </h4> Limited number of medications are available for the post-exposure prophylaxis of COVID-19 infection. Whether bromhexine can prevent or mitigate symptomatic infection after virus exposure is undetermined. Methods A multi-center randomized; double-blind, placebo-controlled clinical trial was conducted. The 372 adults (≥ 18 years) who had close contact within 4 days with a household member with co...

Topics

Open a Topic to create a Post that cites this publication.

• Biosensing Techniques
• COVID-19 Drug Treatment
• COVID-19 Vaccines
• Dexamethasone
• Glucocorticoids
• Molecular Diagnostic Techniques
• Nucleic Acid Amplification Techniques
• World Health Organization

Identifiers and source

Literature Corpus work

9d68ec1c-3a33-5e08-902f-467e5f456758

DOI

10.21203/rs.3.rs-1612290/v1